AGP Executive Report
Last update: 2 hours agoFDA & Rare Disease: Regeneron’s Pasatru (garetosmab-grts) wins FDA approval for adults with fibrodysplasia ossificans progressiva, aiming to cut new heterotopic ossification lesions and flare-ups. Longevity Science: Immunis chair Dr. Hans Keirstead is set to speak at SXSW 2027 on “restorative” longevity medicine, highlighting cell-free, stem-cell-derived approaches. Clinical Trials Ecosystem: A JAMA Oncology analysis finds federal and industry sponsors play different roles in cancer trials, with industry skewing toward single-agent studies and federal funding more often covering prevention, supportive care, and de-escalation. Antibiotics Guidance: A new study finds most Americans still believe you should always finish antibiotics, even though current guidance is more nuanced. Workplace Tech & Privacy: AP reports employers using AI and digital monitoring to track workers’ locations and productivity, raising fresh privacy concerns. Identity & Biometrics: Illinois BIPA claims move forward against Otter.ai over voiceprint handling. Telecom Security: Sabah logged 1,191 telecom disruption incidents (2025–June 2026), tied to vandalism and theft. Quantum Race: The U.S. pushes quantum tech from labs toward manufacturing and supply chains to match China’s momentum. Space: NASA’s Swift rescue mission fails as a satellite can’t fix attitude control issues, leaving the observatory on track to reenter later this year.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
